Companies / EXL

ELIXINOL WELLNESS LIMITED

ASX:EXLHousehold & Personal ProductsSuspended from quotation
414.0M shares on issueASX (delayed) · as of 28 July 2026$0.007price · delayed$2.9Mmarket cap · indicative
NR
Dilution grade

Not rated — the company is suspended from quotation

Cash runwayno data — suspended — grade not computed
Share-count growth (24m)no data — suspended — grade not computed
Raise cadence (24m)0 cash raises
Options & rights overhangomitted — option-line data cannot be adjusted for the share consolidation on record in the last 24 months
In-the-money supplyomitted — option-line data cannot be adjusted for the share consolidation on record in the last 24 months
Pending proposed issuesnone

ELIXINOL WELLNESS LIMITED had 414M ordinary shares as of December 2025. Between data observations there is no share-count change percentage provided. The company raised capital five times in the 24-month window for disclosed proceeds totaling A$6.6M, most recently by a Non-pro rata offer under disclosure document / PDS in September 2025. Options overhang is omitted because outstanding option-line data cannot be adjusted for the recent share consolidation. At the June 2026 quarter the company reported A$892K in cash. There are no proposed securities issues (Appendix 3B) pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
Max option dilution · omitted
ITM option dilution
3
Raises · last 12 months
2.7 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 414.0M per ASX (delayed) (28 July 2026).
260.1M316.6M373.1MDec 24Oct 25July 26Cash raise · 15 Sept 2025Cash raise · 8 Sept 2025Cash raise · 3 Sept 2025Cash raise · 12 May 2025

Cash runway

2.7 qtrs
Two to four quarters of funding at the recent spend rate.
$892k available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
15 Jan 20263H · cancellationORDINARY FULLY PAID414.0MAppendix 3H
9 Dec 20252A · quoted issueEXL : ORDINARY FULLY PAID414.0MAppendix 2A
7 Dec 20253G · unquotedEXL : ORDINARY FULLY PAID414.0MAppendix 3G
25 Nov 20253H · cancellationEXL : ORDINARY FULLY PAID414.0MAppendix 3H
21 Nov 20252A · quoted issueEXL : ORDINARY FULLY PAID414.0MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

5 cash raises in the last 24 months · 3 in the last 12 months

Non-pro rata offer under disclosure document / PDS
15 Sept 2025 LOCKED
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

Options summary omitted. option-line data cannot be adjusted for the share consolidation on record in the last 24 months

Director dealings

DateDirectorTypeSharesOptionsValueSource
1 June 2026Gavin EvansBuy497k3Y notice
19 Dec 2025Gavin EvansBuy7.8M50.0M$4k3Y notice
9 Dec 2025Gavin EvansOther7.8M7.8M3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.